Propoxyphenyl sildenafil
(right click,save link as to download,it is a temp file,please download as soon as possible, you can also use CTRL+S to save the whole html page)
Basic Info
FADB-China ID | C0587 |
Substance Name | PDE-5 inhibitors or its analogs |
Substance Chinese Name | PDE-5抑制剂或类似物 |
Molecular Name | Propoxyphenyl sildenafil |
Molecular Chinese Name | 西地那非杂质 |
2D Structure | |
CAS Number | 877777-10-1 |
PubChem CID | 135565675 |
Formula | C23H32N6O4S |
IUPAC Name | 1-methyl-5-[5-(4-methylpiperazin-1-yl)sulfonyl-2-propoxyphenyl]-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-7-one |
InChI Key | KTHQLYOWYJTHOD-UHFFFAOYSA-N |
InChI | InChI=1S/C23H32N6O4S/c1-5-7-18-20-21(28(4)26-18)23(30)25-22(24-20)17-15-16(8-9-19(17)33-14-6-2)34(31,32)29-12-10-27(3)11-13-29/h8-9,15H,5-7,10-14H2,1-4H3,(H,24,25,30) |
Canonical SMILES | CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCCC)C |
Isomeric SMILES | CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCCC)C |
CFM-ID 3.0 | URL Link |
Related links | Processing |
Addition Purposes | Enhance health care function |
Molecular Synonyms | 877777-10-1 O-Desethyl o-propyl sildenafil UNII-2JW56253DF 2JW56253DF 1,6-Dihydro-1-methyl-5-(5-((4-methyl-1-piperazinyl)sulfonyl)-2-propoxyphenyl)-3-propyl-7H-pyrazolo(4,3-d)pyrimidin-7-one 7H-Pyrazolo(4,3-d)pyrimidin-7-one, 1,6-dihydro-1-methyl-5-(5-((4-methyl-1-piperazinyl)sulfonyl)-2-propoxyphenyl)-3-propyl- Piperazine, 1-((3-(4,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-d)pyrimidin-5-yl)-4-propoxyphenyl)sulfonyl)-4-methyl- Propoxyphenyl sildenafil 1-Methyl-5-(5-((4-methylpiperazin-1-yl)sulfonyl)-2-propoxyphenyl)-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one |
Data Uploader | Shuyu Ouyang |
Update Date | Jul 25, 2019 20:46 |
Properties
Property Name | Property Value |
---|---|
Molecular Weight | 488.6 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 8 |
Complexity | 854 |
Monoisotopic Mass | 488.22057471 |
Exact Mass | 488.22057471 |
XLogP | 2 |
Formal Charge | 0 |
Heavy Atom Count | 34 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
ADMET
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.6964 |
Human Intestinal Absorption | HIA+ | 1.0000 |
Caco-2 Permeability | Caco2+ | 0.8046 |
P-glycoprotein Substrate | Substrate | 0.7341 |
P-glycoprotein Inhibitor | Inhibitor | 0.6389 |
Inhibitor | 0.8804 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.6453 |
Distribution | ||
Subcellular localization | Mitochondria | 0.4306 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.6868 |
CYP450 2D6 Substrate | Substrate | 0.7337 |
CYP450 3A4 Substrate | Substrate | 0.7294 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.8360 |
CYP450 2C9 Inhibitor | Inhibitor | 0.7990 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.8787 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.7818 |
CYP450 3A4 Inhibitor | Inhibitor | 0.8212 |
CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.5603 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8116 |
Inhibitor | 0.7240 | |
AMES Toxicity | Non AMES toxic | 0.5627 |
Carcinogens | Non-carcinogens | 0.5888 |
Fish Toxicity | High FHMT | 0.9872 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.8918 |
Honey Bee Toxicity | Low HBT | 0.6946 |
Biodegradation | Not ready biodegradable | 0.8547 |
Acute Oral Toxicity | III | 0.5202 |
Carcinogenicity (Three-class) | Non-required | 0.5993 |
ADMET -- Regression
Model | Value | Unit |
---|---|---|
Aqueous solubility | -3.9325 | LogS |
Caco-2 Permeability | 1.1418 | LogPapp, cm/s |
Rat Acute Toxicity | 2.7687 | LD50, mol/kg |
Fish Toxicity | 1.4204 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | 0.5432 | pIGC50, ug/L |
Related Foods
FADB-China ID | F0142 |
Food Image | ![]() |
Food Name | Plant food supplements |
Food Chinese Name | 植物食品补充剂 |
Food Type | Processed food |
References | Adulteration of Dietary Supplements by the Illegal Addition of Synthetic Drugs: A Review |